|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.88 USD | +0.92% |
|
-7.01% | -19.35% |
| Fiscal Period: January | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.9 | 0.87 | 0.76 | 2.56 | 3.84 | |||||
Return on Total Capital | 2.09 | 0.95 | 0.82 | 2.73 | 4.1 | |||||
Return On Equity % | 0.73 | -2.74 | -1.39 | 2.83 | 4.66 | |||||
Return on Common Equity | 0.73 | -2.74 | -1.39 | 2.83 | 4.66 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.62 | 56 | 56.87 | 62.29 | 64.78 | |||||
SG&A Margin | 18.33 | 18.9 | 19.09 | 18.3 | 18.59 | |||||
EBITDA Margin % | 26.71 | 23.5 | 23.08 | 28.13 | 30.45 | |||||
EBITA Margin % | 24.52 | 21.55 | 21.65 | 27.25 | 30.06 | |||||
EBIT Margin % | 10.91 | 5.36 | 4.37 | 12.82 | 16.91 | |||||
Income From Continuing Operations Margin % | 1.2 | -5.85 | -3.03 | 5.57 | 8.06 | |||||
Net Income Margin % | 1.2 | -5.85 | -3.03 | 5.57 | 8.06 | |||||
Net Avail. For Common Margin % | 1.2 | -5.85 | -3.03 | 5.57 | 8.06 | |||||
Normalized Net Income Margin | 3.79 | 0.6 | -0.69 | 5.34 | 8.16 | |||||
Levered Free Cash Flow Margin | 13.22 | 9.21 | 8.08 | 21.2 | -12.11 | |||||
Unlevered Free Cash Flow Margin | 15.5 | 11.65 | 11.22 | 24.38 | -9.13 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.28 | 0.26 | 0.28 | 0.32 | 0.36 | |||||
Fixed Assets Turnover | 6.24 | 7.36 | 11.03 | 16.16 | 23.8 | |||||
Receivables Turnover (Average Receivables) | 10.21 | 9.45 | 9.35 | 9.91 | 10.77 | |||||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.25 | 2.29 | 2.92 | 4.76 | 3.06 | |||||
Quick Ratio | 1.96 | 2.04 | 2.68 | 4.35 | 2.65 | |||||
Operating Cash Flow to Current Liabilities | 0.89 | 0.92 | 1.15 | 2.07 | 2.17 | |||||
Days Sales Outstanding (Average Receivables) | 35.83 | 38.64 | 39.02 | 36.83 | 34 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||||
Average Days Payable Outstanding | 3.22 | 15.99 | 20.35 | 12.56 | 11.43 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 77.97 | 54.42 | 52.46 | 45.85 | 52.41 | |||||
Total Debt / Total Capital | 43.81 | 35.24 | 34.41 | 31.44 | 34.39 | |||||
LT Debt/Equity | 72.42 | 53.29 | 51 | 45.39 | 51.94 | |||||
Long-Term Debt / Total Capital | 40.69 | 34.51 | 33.45 | 31.12 | 34.08 | |||||
Total Liabilities / Total Assets | 49.13 | 40.38 | 38.63 | 35.68 | 38.67 | |||||
EBIT / Interest Expense | 2.29 | 1.11 | 0.78 | 2.31 | 3.35 | |||||
EBITDA / Interest Expense | 6.03 | 5.21 | 4.3 | 5.19 | 6.11 | |||||
(EBITDA - Capex) / Interest Expense | 5.65 | 4.97 | 4.23 | 5.16 | 6.07 | |||||
Total Debt / EBITDA | 5.11 | 5.29 | 4.78 | 3.24 | 2.99 | |||||
Net Debt / EBITDA | 3.55 | 4.11 | 3.56 | 1.84 | 2.19 | |||||
Total Debt / (EBITDA - Capex) | 5.45 | 5.55 | 4.86 | 3.26 | 3.01 | |||||
Net Debt / (EBITDA - Capex) | 3.79 | 4.31 | 3.62 | 1.85 | 2.21 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 37.89 | 3.13 | 13.9 | 16 | 20.03 | |||||
Gross Profit, 1 Yr. Growth % | 27.44 | 2.02 | 15.67 | 26.57 | 24.83 | |||||
EBITDA, 1 Yr. Growth % | 19.12 | -9.27 | 11.87 | 41.42 | 29.91 | |||||
EBITA, 1 Yr. Growth % | 15.61 | -9.36 | 14.4 | 46.04 | 32.39 | |||||
EBIT, 1 Yr. Growth % | -26.68 | -49.29 | -7.18 | 240.3 | 58.33 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -77.73 | -601.35 | -40.97 | -313.1 | 73.58 | |||||
Net Income, 1 Yr. Growth % | -77.73 | -601.35 | -40.97 | -313.1 | 73.58 | |||||
Normalized Net Income, 1 Yr. Growth % | -49.67 | -85.94 | -231.14 | -1K | 83.18 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -79.48 | -547.69 | -41.81 | -306.45 | 70.31 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.69 | 20.15 | 10.76 | 8.32 | 12.5 | |||||
Inventory, 1 Yr. Growth % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.67 | -26.67 | -20.3 | -21.54 | -14.65 | |||||
Total Assets, 1 Yr. Growth % | 5.67 | 14.64 | -0.59 | 2.42 | 9 | |||||
Tangible Book Value, 1 Yr. Growth % | -34.1 | 7.12 | -10.12 | -34.81 | 64.31 | |||||
Common Equity, 1 Yr. Growth % | 33.82 | 34.37 | 2.32 | 7.35 | 3.93 | |||||
Cash From Operations, 1 Yr. Growth % | 72.95 | -22.37 | 6.85 | 61.19 | 39.96 | |||||
Capital Expenditures, 1 Yr. Growth % | 79.7 | -31.96 | -62.16 | -49.75 | 23.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -14.3 | -28.15 | -0.07 | 204.22 | -168.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -9.73 | -22.51 | 9.7 | 152.13 | -144.93 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 59.81 | 19.25 | 8.38 | 14.94 | 17.99 | |||||
Gross Profit, 2 Yr. CAGR % | 51.4 | 14.02 | 8.63 | 21.07 | 25.7 | |||||
EBITDA, 2 Yr. CAGR % | 42.96 | 3.96 | 0.75 | 25.78 | 35.54 | |||||
EBITA, 2 Yr. CAGR % | 39.56 | 2.37 | 1.83 | 29.26 | 39.04 | |||||
EBIT, 2 Yr. CAGR % | 1.49 | -39.03 | -31.4 | 77.72 | 132.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -65.43 | 5.67 | 72.03 | 12.16 | 92.33 | |||||
Net Income, 2 Yr. CAGR % | -65.43 | 5.67 | 72.03 | 12.16 | 92.33 | |||||
Normalized Net Income, 2 Yr. CAGR % | -24.53 | -71.44 | -57.07 | 244.46 | 307.1 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -68.11 | -4.16 | 61.4 | 9.6 | 87.51 | |||||
Accounts Receivable, 2 Yr. CAGR % | 68.37 | 11.07 | 15.36 | 9.53 | 10.39 | |||||
Inventory, 2 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 279.8 | -13.65 | -23.55 | -20.92 | -18.17 | |||||
Total Assets, 2 Yr. CAGR % | 130.53 | 10.06 | 6.75 | 0.91 | 5.66 | |||||
Tangible Book Value, 2 Yr. CAGR % | 34.97 | -15.98 | -1.88 | -23.45 | 3.5 | |||||
Common Equity, 2 Yr. CAGR % | 70 | 34.09 | 17.26 | 4.81 | 5.63 | |||||
Cash From Operations, 2 Yr. CAGR % | 26.54 | 15.87 | -8.92 | 31.23 | 50.2 | |||||
Capital Expenditures, 2 Yr. CAGR % | 83.96 | 10.57 | -49.26 | -56.39 | -21.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 15.17 | -21.53 | -15.26 | 74.36 | 44.45 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 24.6 | -16.36 | -7.8 | 66.31 | 6.44 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 47.3 | 38.1 | 17.44 | 10.86 | 16.61 | |||||
Gross Profit, 3 Yr. CAGR % | 45.47 | 32.73 | 14.57 | 14.45 | 22.31 | |||||
EBITDA, 3 Yr. CAGR % | 40.68 | 22.86 | 6.53 | 12.8 | 27.14 | |||||
EBITA, 3 Yr. CAGR % | 38.57 | 20.86 | 6.23 | 14.83 | 30.29 | |||||
EBIT, 3 Yr. CAGR % | 13.71 | -19.47 | -29.86 | 17 | 71.01 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -42.86 | -15.69 | -12.97 | 84.76 | 29.73 | |||||
Net Income, 3 Yr. CAGR % | -42.86 | -15.69 | -12.97 | 84.76 | 29.73 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.51 | -54.81 | -52.53 | 18.59 | 179.07 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -46.34 | -23.07 | -18.85 | 75.2 | 26.95 | |||||
Accounts Receivable, 3 Yr. CAGR % | 49.9 | 50.46 | 10.97 | 12.96 | 10.51 | |||||
Inventory, 3 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 147.37 | 119.52 | -15.93 | -22.89 | -18.89 | |||||
Total Assets, 3 Yr. CAGR % | 94.36 | 82.64 | 6.39 | 5.29 | 3.54 | |||||
Tangible Book Value, 3 Yr. CAGR % | 40.5 | 24.96 | -14.07 | -14.38 | -1.26 | |||||
Common Equity, 3 Yr. CAGR % | 58.5 | 57.18 | 22.54 | 13.86 | 4.51 | |||||
Cash From Operations, 3 Yr. CAGR % | 30.51 | 7.52 | 12.78 | 10.17 | 34.08 | |||||
Capital Expenditures, 3 Yr. CAGR % | 33.87 | 32.05 | -22.66 | -49.42 | -38.38 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 46.52 | -1.59 | -14.94 | 29.75 | 27.75 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 54.2 | 6.36 | -8.45 | 28.93 | 7.51 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 42.06 | 33.51 | 30.29 | 28.33 | 17.66 | |||||
Gross Profit, 5 Yr. CAGR % | 41.74 | 31.84 | 29.43 | 28 | 18.99 | |||||
EBITDA, 5 Yr. CAGR % | 41.33 | 26.72 | 23.09 | 24.02 | 17.31 | |||||
EBITA, 5 Yr. CAGR % | 40.17 | 25.48 | 22.5 | 24.15 | 18.31 | |||||
EBIT, 5 Yr. CAGR % | 25.07 | -0.32 | -7.1 | 10.53 | 13.2 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -11.87 | 10.92 | -11.21 | -5.49 | 19.51 | |||||
Net Income, 5 Yr. CAGR % | -11.87 | 10.92 | -11.21 | -5.49 | 19.51 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.3 | -29.29 | -29.54 | 1.84 | 12.13 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -15.73 | 3.9 | -16.64 | -11.37 | 13.45 | |||||
Accounts Receivable, 5 Yr. CAGR % | 38.44 | 38.75 | 34.99 | 32.52 | 10.74 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 102.24 | 75.87 | 54.65 | 45.92 | -16.83 | |||||
Total Assets, 5 Yr. CAGR % | 65.27 | 61.92 | 52.94 | 44.05 | 6.1 | |||||
Tangible Book Value, 5 Yr. CAGR % | 40.23 | 31.86 | 21.7 | 2.72 | -7.43 | |||||
Common Equity, 5 Yr. CAGR % | 46.62 | 47.88 | 40.5 | 33.66 | 15.47 | |||||
Cash From Operations, 5 Yr. CAGR % | 46.91 | 25.33 | 13.02 | 16.44 | 26.48 | |||||
Capital Expenditures, 5 Yr. CAGR % | 40.68 | 19.57 | -9.19 | -15.23 | -22.15 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 35.47 | 13.56 | 17.7 | 23.71 | 5.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 39.89 | 18.9 | 25.53 | 27.18 | -2.76 |
- Stock Market
- Equities
- HQY Stock
- Financials HealthEquity, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















